Perspective Therapeutics, Inc. CATX
i
Market datapartial · fetched 2026-11-04T07:15:32.994Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-04T01:00:00.079328931Z
FundamentalsAlpha Vantage · unavailable
Perspective Therapeutics, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 0.72 | 703.8% | 74.7% | |||
| 25Δ | 0.86 | 644.9% | 59.2% | |||
| 30Δ | 0.99 | 586.0% | 43.8% | |||
| 35Δ | 7.30 | 800.0% | 786.0% | |||
| 40Δ | 5.92 | 800.0% | 629.7% | |||
| 45Δ | 4.77 | 800.0% | 498.3% | |||
| 50Δ | 4.05 | 800.0% | 417.5% | |||
| 55Δ | 3.34 | 800.0% | 336.7% | |||
| 60Δ | 2.63 | 800.0% | 255.9% | |||
| 65Δ | 1.95 | 800.0% | 178.9% | |||
| 70Δ | 1.54 | 800.0% | 132.0% | |||
| 75Δ | ||||||
| 80Δ | 0.80 | 686.0% | 48.2% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.72
- IV
- 703.8%
- B/E move
- 74.7%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.86
- IV
- 644.9%
- B/E move
- 59.2%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 0.99
- IV
- 586.0%
- B/E move
- 43.8%
35Δ
- Pseudo strike
- 7.30
- IV
- 800.0%
- B/E move
- 786.0%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 5.92
- IV
- 800.0%
- B/E move
- 629.7%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 4.77
- IV
- 800.0%
- B/E move
- 498.3%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 4.05
- IV
- 800.0%
- B/E move
- 417.5%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 3.34
- IV
- 800.0%
- B/E move
- 336.7%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 2.63
- IV
- 800.0%
- B/E move
- 255.9%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 1.95
- IV
- 800.0%
- B/E move
- 178.9%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 1.54
- IV
- 800.0%
- B/E move
- 132.0%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 0.80
- IV
- 686.0%
- B/E move
- 48.2%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 243.63% | |
| 272.96% | |
| 281.19% | |
| 309.05% | |
| 271.45% |
Medical Devices
CBLL
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in…
More →CERS
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in…
More →CLPT
ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.
More →CNMD
CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company…
More →CTKB
Description unavailable
More →CVRX
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
More →